SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000850261-20-000029
Filing Date
2020-03-05
Accepted
2020-03-05 13:58:44
Documents
1
Period of Report
2020-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158343470683588.html 4  
1 FORM 4 wf-form4_158343470683588.xml 4 3552
  Complete submission text file 0000850261-20-000029.txt   5039
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE NY 11747
Business Address
Smith Robin L (Reporting) CIK: 0001365035 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 20690293